Lymphocytes and related cell lines are predominantly CD13-negative, however, there are reports describing neutral aminopeptidase activity in or on these cells. The aim of this study was to answer the question, whether this activity originates from APN-gene expression.
Ž .

Biochimica et Biophysica Acta 1355 1997 147-154
The main neutral aminopeptidase activity of human lymphoid tumour ž / cell lines does not originate from the aminopeptidase N-APN; CD13 gene T. Wex ) , U. Lendeckel, T. Kahne, A. Ittenson, K. Frank, S. Ansorgë
Introduction
APN is expressed in many tissues including intestine, kidney, liver as well as the central nervous w x system 1,2 . The enzyme is involved in the final Abbreviations: Ala-b NA, alanine-b-methoxy-naphthylamide; Ala-pNA, alanine-p-nitroanilide; APN, aminopeptidase N; HUVE-cells, human umbilical vein endothelial cells; IEF, isoelectric focusing; IP, isoelectric point; PBS, phosphate buffered saline; RT, reverse transcription ) Corresponding author. Fax: q49 391 6713291; E-mail thomas.wex@medizin.uni-magdeburg.de hydrolysis of nutrients and the degradation of bioacw x tive molecules such as tuftsin and cytokines 3-5 . Furthermore, APN serves as a receptor for corona w x viruses 6,7 , and it is possibly involved in processes w x of antigen presentation 8 . Recently, Saiko and coworkers have shown that the CD13 antigen is involved in the regulation of tumour-cell invasion and w x the degradation of extracellular matrix 9 . In the diagnostic of hematopoietic malignant disorders APN is used as a routine marker for myelomonocytic cells w x 3,10 . Other cells such as lymphocytes and related w x cell lines are predominantly CD13-negative 1,10,11 . However, there are several reports describing the 0167-4889r97r$17.00 Copyright q 1997 Elsevier Science B.V. All rights reserved.
Ž . PII S0167-4889 96 00132-2 ( )occurrence of neutral aminopeptidase activities in or on these cells. Amoscato and co-workers reported on Ala-pNA-hydrolysing activity located on the cell surw x face of lymphoid cell lines 12 . Other reports extended these findings showing that APN is expressed on peripheral blood lymphocytes and on lymphoid T w x cell lines as well 13,14 . It was also shown that the CD13 antigen is frequently expressed on the surface w x of malignant B cells 15 , on T lymphocytes derived w x from inflamed tissues 16 as well as on mitogen w x activated T cells 17 .
Other reports describe, however, that peripheral blood lymphocytes, Jurkat T cells and tumour cells separated from patients suffering from leukeamia express neutral aminopeptidase activity which is distinct from APN with respect to its biochemical properties such as substrate specificity, sensitivity to inw x hibitors, or CD13-immunoreactivity 18-20 . In the studies presented here, we investigated neutral aminopeptidase activity of cell lines to answer the question, whether this activity originates from the APN-gene and then would represent a modified APN, or whether it has to be attributed to another aminopeptidase.
Materials and methods
Cell cultures
The CD13-positive histiocytic cell line U937-H and the lymphoid cell lines H9, HuT78, Daudi and Jurkat were obtained from American Type Culture Ž . Collection ATTC, Rockville, MD, USA , the CD13-negative cell clone U937-L, as well as the lymphoid cell lines Karpas and PC12 Ichikawa cells were supplied by the German Collection of Microor-Ž ganisms and Cell Cultures DSM, Braunschweig, . Ž Germany . Cells were grown in IMDM GibcoBRL, . Eggenstein, Germany supplemented with 10% foetal Ž . Ž . calf serum Gibco and 60 Urml penicillin Gibco . Peripheral T cells were purified by nylon adherence w x as described by others 32 .
Isoelectric focusing
Cells were solubilized in 1% n-octyl-b-D-gluco-Ž . pyranoside in PBS pH 7.4 , and particulate materials Ž were sedimented by ultracentrifugation 30 min, . 100 000 = g . IEF and capillary blotting were perw x formed as previously described 14 . Blots were used for activity staining of neutral aminopeptidase by means of the chromogenic substrate Ala-b-methoxy-Ž . Ž naphthylamide 5 mgr10 ml and Fast Blue B 10 . Ž . mgr10 ml in PBS pH 7.4 .
Enzymatic assay
Neutral aminopeptidase activity was determined in triplicate by measuring the hydrolysis of the chromogenic substrate Ala-pNA in a photometric assay as w x described previously 14 . Briefly, cells or subcellular fractions, respectively, were incubated in 100 ml PBS Ž . pH 7.4 containing 2.5 mM Ala-pNA. Reactions were stopped by adding 0.4 ml 1 M sodium acetate Ž . Ž . pH 4.4 , either immediately control or after 60 min of incubation at 378C. After centrifugation for 5 min at 48C, absorption of the cell-free supernatants at 390 Ž nm was determined using a Spekol 21 Carl Zeiss . Jena .
Cell fractionation
Ž
. Cells were resuspended in PBS pH 7.4 and soni-Ž cated using a Vibra cell Sonics and Materials, Dan-. Ž . bury, CT, USA at 40 W for 2 min 3 = 40 s . Cytosolic and particulate fractions were separated by Ž . ultracentrifugation 48C, 100 000 = g, 2 h of the lysate. . Leu-M7, Becton Dickenson . For control of nonspecific or Fc-receptor mediated labelling, binding of irrelevant immunoglobulin was determined. This control value was set to 2%. Cytofluorimetric analyses were performed using the EPICS PROFILE II Ž . Coulter Electronics .
Plasmid construction and transfection
CompetitiÕe PCR
Competitive PCR was performed as described prew x viously 24 . Briefly, RNA was extracted using Ž . 'RNeasy' kit Qiagen . Five hundred ng total RNA from cells was mixed with an aliquot of a given dilution of the standard APN-RNA-fragment, and transcribed into cDNA by 50 U MML-V reverse Ž X transcriptase using 1 ng APN-specific primer 5 -gcg-X . gtagaagcccgccaggtca-3 . An aliquot of the cDNA mixture was used directly for enzymatic amplifications which were performed in 30 ml reaction volume Ž containing 0.5 U 'Gold-Star' polymerase Eurogen-. tec , 0.25 mM dNTP, 2.5 mM MgCl , 0.2 pmol of 2 Ž X X primers forward: 5 -gccgtgtgcacaatcatcgcact-3 ; re-X X . verse: 5 -caccagggagcccttgaggtg-3 and 1 = reaction Ž . Ž buffer Eurogentec in an Autogene II CLF, Emmer-. sacker, Germany . Initial denaturation at 948C for 3 min was followed by thirty cycles with denaturation at 958C for 0.7 min, annealing at 548C for 0.6 min and elongation at 728C for 1.3 min. The final extension step was at 728C for 10 min. Electrophoresis of reaction products as well as calculation of the APNmRNA contents was performed as described previw x ously 24 .
Results
Neutral aminopeptidase actiÕity
The neutral aminopeptidase activities of cell lines were investigated by assaying their capability to hydrolyse the chromogenic substrate Ala-pNA. Total cellular activities measured in the lysate of lymphoid cell lines were in the range of 23 to 172 pkatr10 6 cells. In comparison with the corresponding activity Ž
6
. of peripheral T cells 12 pkatr10 cells , related cell lines showed substantially higher aminopeptidase ac-Ž . tivities Table 1 . The CD13-positive histiocytic cell line U937-H contained 63 pkatr10 6 cells Ala-pNA hydrolysing activity. Surprisingly, some of the CD13-negative lymphoid cell lines such as the B cell line Daudi, the T cell lines H9, PC12-Ichikawa, and the weakly CD13-expressing T cell line Karpas contained higher neutral aminopeptidase activities than Ž . U937-H cells Table 1 . The majority of this activity expressed in lymphoid cells as well as in the CD13- 47 " 9 U937-L 42 " 13 7 " 2 1-3 0.5 " 0.4 Daudi 172 " 90 18 " 6 1-2 2.0 " 0.8 Jurkat 23 " 10 7 " 2 1-2 1.9 " 0.6 H9 85 " 41 6 " 4 1-2 6.2 " 5.6 HuT78 41 " 19 4 " 1 1-3 6.5 " 5.0 PC12 74 " 19 13 " 5 1 1.9 " 1.0 Karpas 105 " 31 13 " 4 9-27 12.6 " 3.9 T cells 12 " 3 3 " 1 1-3 2.0 " 0.9
Enzymatic data represent the means of at least 5 experiments. Cell surface expression was determined by immunofluorescence analysis in Ž . three separate experiments using My-7 Coulter as described in Section 2. APNmRNA contents of cell lines and peripheral T cells are the means of three experiments. Table 1 .
Activity-staining of isoelectrically focused cell lysates using Ala-b NA revealed the presence of different enzyme species. The main enzymatic activity of U937-H cells represents proteins with isoelectric Ž . points between 4.8 and 3.5 Fig. 1 
Detection of APN surface expression and APNmRNA
The cell surface expression of cell lines was measured using anti-CD13 monoclonal antibodies. The level of cell surface expression mainly corresponded to the presence of Ala-pNA-hydrolysing activity detected in particulate fractions. Strong CD13-surface expression was found on the histiocytic cell line U937-H only, and to some lower extent on the T cell line Karpas, expressing Ala-pNA hydrolysing activity of 40 pkatr10 6 To investigate whether the neutral aminopeptidase activity detected in the soluble fraction of lymphoid cells results from APN-gene expression, we quanti-Ž fied APNmRNA contents by competitive PCR Table  . 1 . The CD13-positive U937-H cells contained 47 pg APN-transcript per mg total RNA, whereas 13 pg APN-transcript per mg total RNA were determined in the T cell line Karpas, which expresses CD13 at a lower level than U937-H cells. The APN-transcript levels of the T cell lines H9 and HuT78 were 6 or 7 pg per mg total RNA, respectively, whereas corre- 
Antisense-mediated inhibition of APN-gene expression
Two plasmids were constructed containing a 2.8 Ž . kb APNcDNA-insert in either antisense pREP4AA Ž . or sense pREP4AS orientation under the control of the RSV-LTR. Both variants were used to transfect the cell lines H9 and U937-H. Both the presence of the plasmids and the transcription of the inserted Ž APN fragment in the transfectants antisense: H9. 13 . and U937.16; sense: H9.2, U937.18 were confirmed Ž . by in situ-hybridization data not shown .
The inhibition of the cellular APN expression in the U937-H transfectants was shown by indirect immunofluorescence analyses. The antisense transfectants U937.16 show a marked decrease of their CD13-immunoreactivity compared to wildtype cells Ž . or sense transfectants U937.18 Fig. 2 . Furthermore, loss of the APN-derived enzymatic activity could be demonstrated using IEF analysis. The Ala-b NA hydrolysing activities with IPs between 3.6-4.8 were completely absent in antisense transfectants U937.16 Ž . Fig. 3 . On the contrary, these activities are still Ž . present in the U937 wildtype cells as well as in the Ž . sense transfectants U937.18 Fig. 3 . Furthermore, IEF analyses revealed that the antisense H9 cells Ž . H9.13 also completely lacked their minor Ala-b NA hydrolysing activity with an IP 4.8, whereas this activity was still present in the wildtype cells H9 as Ž . well as in the control cells H9.2 Fig. 3 . This result strongly underlines that the Ala-b NA hydrolysing activity with an IP of 4.8 which is expressed in H9 cells represents APN. Interestingly, the activity with an IP of 5.4 is increased in the H9.13 cells. An induction of this activity was also observed in Ž . U937.16 cells Fig. 3 . 
Discussion
We investigated neutral aminopeptidase activities of different hematopoietic cell lines. Although APN expression within the immune system is largely restricted to cells of the myelomonocytic lineage, there are data providing evidence that lymphoid cells express APN on their surface after mitogenic activation w x w x 17,25,28 or malignant transformation 15,22 . This induction of CD13-expression is always accompanied by an increase of corresponding enzymatic activity w x 17 .
Data presented here show that neutral aminopeptidase activities of lymphoid cell lines are 2-15 times higher compared to peripheral T or B cells, respecw x tively 23 . On the contrary, corresponding activities of the histiocytic cell lines U937-H and -L were found similar to those determined on normal monow x cytes 23 . Interestingly, with the exception of Karpas cells enzymatic activities of all lymphoid cell lines were not accompanied by the appearance of CD13-immunoreactivity. The absence of CD13-surface expression correlates with low enzymatic activity detected in the particulate fractions of most lymphoid cells except Daudi and PC12. At least for Daudi this fact is due to the higher aminopeptidase activity of Ž
6
. these cells 172 pkatr10 cells .
To investigate whether high enzymatic activities located in the soluble fraction are related to APN expression we studied APN-transcript levels by competitive RT-PCR. The CD13-positive cell line U937-H contains APN-transcript in amounts comparable to renal carcinoma cells, which strongly express CD13 w x 25 . The APNmRNA-contents of most lymphoid cell lines studied here are below 7 pgrmg total RNA. These values are in accordance to data reported from Riemann and co-workers, who estimated the APNmRNA content as 4-6 pgrmg total RNA in the T Ž . cell line HuT78 personal information . These low APN-transcript levels suggest that the considerable amounts of neutral aminopeptidase activity detected in the cytosol of lymphoid cell lines could hardly originate from the APN-gene expression.
The enzymatic pattern of the isoelectric focusing revealed the presence of two enzyme species which both represent neutral aminopeptidase activity. As we showed previously, the species with an IP of 4.8 represents the membrane-bound APN in U937-H cells w x 14 . Although we used different monoclonal antibodies, we did never detect CD13-immunoreactivity of the enzyme form with an IP of 4.8 in lymphoid cells. Perhaps, this effect could be explained by the weak APN expression in lymphoid cells. Recent biochemical studies using inhibitors and the inhibitory mono-( )clonal anti-CD13 antibody WM15 underlined the different nature of the two neutral aminopeptidase activities, but they do not definitively answer the question, whether both enzyme species represent APN. The detection of additional aminopeptidase activities in the lymphoid cells is in agreement with data from w x other groups. Favaloro and co-workers 27 have shown that only 20-40% of the total neutral aminopeptidase activity of acute myeloid or lymphoid leukaemic cells could be attributed to APN. The authors discussed a high complexity of the protease expression pattern of the malignant clones. Using the inhibitory monoclonal antibody WM15 they obtained quite similar results concerning neutral aminopeptiw x dase expression of peripheral T cells 20 . Interestingly, Belhacene and co-workers showed that aminopeptidase B is the main aminopeptidase activity of w x the T cell line Jurkat 19 . Furthermore, Murray and co-workers described an aminopeptidase activity of Jurkat cells which has to be distinguished from APN w x 18 .
To definitively clarify the possible relation between the cytosolically located activity detected in lymphoid cell lines and the APN we established transfectants lacking cellular APN expression. Functioning of our antisense model was confirmed by transfecting CD13-positive U937-H cells. The strong reduction of CD13-immunoreactivity on the antisense transfectants U937.16 as well as the complete absence of the enzyme species with IP between 3.5 and 4.8 in these cells demonstrate the capability of our antisense system to in inhibit cellular APN expression. Furthermore, the observed variability concern-Ž . ing the isoelectric points between 3.5 and 4.8 implies that the APN-derived activity represents more than one enzyme species. For the first time, the occurrence of different molecular forms of the APN was shown in an enzymatic assay. The heterogeneity observed could be caused by a different extent of glycosylation as shown by O'Connell and co-workers. They demonstrated that changes in the glycosylation pattern of the APN expressed on HUVE-cells create five APN subpopulations defined by different CD13 w x monoclonal antibodies 26 .
Until recently, it was assumed that APN expression within the hematopoietic system is restricted to w x cells of the myelomonocytic lineage 1,3 . Results presented here, prove that the Ala-b NA hydrolysing activity with an IP of 4.8 expressed in H9 cells also represents APN. On the basis of the IEF analysis it could be concluded that a small fraction of the cellular enzymatic activity in H9 cells only could be attributed to the APN.
The antisense mediated inhibition of the APN expression clearly demonstrated that the Ala-b-NA hydrolysing activity with an IP of 5.4 is not due to APN expression because this activity was not decreased in the antisense transfectants derived from U937-H and H9 cells. Therefore, the high neutral aminopeptidase activity expressed in H9 cells has to be attributed to another enzyme. The induction of this activity observed in the U937-H transfectants could be considered, perhaps, as a 'by pass phenomenon' or 'compensation' which is occasionally observed in w x 'knock out' experiments 30,31 .
Due to the fact that neutral aminopeptidase activities of all lymphoid cell lines investigated have biochemical features such as cellular location and isoelectric point similar to those of the T cell line H9, we conclude that the main neutral aminopeptidase activity of all lymphoid cells has to be attributed to another enzyme which is not related to the well-char-Ž . acterised APN EC 3.4.11.2 .
Taken together, the data presented here and our former results, support the model of a low-level constitutive APN expression in T cells and related cell lines which is increased after mitogenic stimulation or malignant transformation as it was demonw x strated by others 13,17,25,28 . This increase is, however, always associated with the appearance of CD13-immunoreactivity on the cell surface. However, besides the APN at least one other cytosolically located enzyme contributes to the total neutral aminopeptidase activity in lymphocytes and related cell lines. This enzyme represents the main neutral aminopeptidase activity of CD13-negative lymphoid cell lines. The nature of this Ala-b NA hydrolysing activity is still unclear. Ž Preliminary biochemical studies gel chromatogra-. phy, sensitivity towards inhibitors and metal ions of this aminopeptidase activity enriched from H9 cells have revealed that it could be distinguished from other well-characterised aminopeptidases such as Ž . leucine-aminopeptidase EC 3.4.11.1 , cytosolic ala-Ž . nine-aminopeptidase EC 3.4.11.14 and puromycinsensitive aminopeptidase. Purification and subsequent ( )biochemical analyses of this aminopeptidase will be the next challenge.
